Physician profile
Devorah A Chock
NPI 1497780209
$6,023.73
in general payments reported to CMS, 2019-2025
11 companies · $95.57 in 2025
The $95.57 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $992 · 2020: $17.82 · 2021: $3,087 · 2022: $182 · 2023: $234 · 2024: $1,415 · 2025: $95.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $887 · Food and Beverage: $858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $887.24 |
| Food and Beverage | $857.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexington Medical, INC. | $2,500.00 | 2021 | |
| Medical Device Business Services, INC. | $1,864.17 | 2019-2024 | |
| Medtronic, INC. | $609.86 | 2022-2024 | Signia |
| Intuitive Surgical, INC. | $536.60 | 2021 | |
| Ethicon US, LLC | $237.54 | 2019-2024 | Echelon; Endopath |
| Novo Nordisk INC | $99.61 | 2019-2025 | Wegovy |
| Corcept Therapeutics | $63.35 | 2025 | Korlym |
| Apollo Endosurgery US INC | $40.04 | 2022 | |
| Lilly USA, LLC | $31.28 | 2023-2025 | Zepbound, Mounjaro |
| Teleflex LLC | $23.46 | 2023 | Titan Sgs Standard Gastric Stapler |
| Endo Pharmaceuticals INC. | $17.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devorah Chock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.